Immunotech Biopharm Ltd
Company Profile
Business description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Contact
No.1 Kangding Street
8th Floor, Block 1, Guosheng Technology Park
Beijing Economic-technological Development Area
Beijing100176
CHNT: +86 1088400152
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
154
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,974.90 | 15.20 | 0.19% |
CAC 40 | 7,273.12 | 168.32 | 2.37% |
DAX 40 | 20,954.83 | 580.73 | 2.85% |
Dow JONES (US) | 40,524.79 | 312.08 | 0.78% |
FTSE 100 | 8,134.34 | 170.16 | 2.14% |
HKSE | 21,471.53 | 54.13 | 0.25% |
NASDAQ | 16,831.48 | 107.03 | 0.64% |
Nikkei 225 | 34,311.79 | 329.43 | 0.97% |
NZX 50 Index | 12,042.33 | 65.21 | -0.54% |
S&P 500 | 5,405.97 | 42.61 | 0.79% |
S&P/ASX 200 | 7,767.90 | 19.30 | 0.25% |
SSE Composite Index | 3,257.69 | 5.12 | -0.16% |